Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$886K
Shares
3,461
Price
$256.08
Executed
Jun 12, 2026
Disclosed
Jun 15, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Jun 12 executedJun 15, 2026 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Haas Jason filed this Form 4 reporting a open-market sale of LGND on Jun 12, 2026. It became public on Jun 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Haas Jasoncik:0001883821
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
